Aurora Cannabis - ACB Stock Forecast, Price & News

Aurora Cannabis Inc. produces, distributes, and sells cannabis and cannabis derivative products in Canada and internationally. It also engages in facility engineering and design, cannabis breeding, research, production, derivatives, product development, wholesale, and retail distribution activities. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and WMMC. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on ACB shares. Cowen lifted their price objective on Aurora Cannabis from C$1.85 to C$2.00 in a research note on Tuesday, July 19th. Piper Sandler cut their target price on Aurora Cannabis from C$7.00 to C$4.00 and set a "hold" rating on the stock in a research report on Friday, May 13th. CIBC cut their target price on Aurora Cannabis from C$6.50 to C$3.75 in a research report on Monday, May 16th. Stifel Nicolaus raised Aurora Cannabis from a "sell" rating to a "hold" rating and cut their target price for the stock from C$2.50 to C$2.15 in a research report on Monday, June 6th. Finally, ATB Capital cut their target price on Aurora Cannabis from C$5.00 to C$4.00 and set an "underperform" rating on the stock in a research report on Tuesday, May 10th. One equities research analyst has rated the stock with a sell rating and seven have issued a hold rating to the company's stock. According to MarketBeat, the company presently has an average rating of "Hold" and an average target price of C$3.99.

Aurora Cannabis Stock Performance

Shares of ACB Stock traded down C$0.16 during midday trading on Friday, hitting C$1.98. The company had a trading volume of 1,771,451 shares, compared to its average volume of 2,107,249. The company's 50 day simple moving average is C$1.88 and its 200 day simple moving average is C$3.37. Aurora Cannabis has a 52-week low of C$1.56 and a 52-week high of C$10.87. The stock has a market cap of C$589.54 million and a price-to-earnings ratio of -0.32. The company has a debt-to-equity ratio of 35.61, a current ratio of 5.85 and a quick ratio of 3.95.